<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00369148</url>
  </required_header>
  <id_info>
    <org_study_id>CS-NHK2</org_study_id>
    <nct_id>NCT00369148</nct_id>
  </id_info>
  <brief_title>Combination of Glinides With Premixed Insulin</brief_title>
  <official_title>Evaluation of Usefulness of Combination Therapy of Rapid Acting Insulin Secretagogue (Glinide) With Premixed Insulin in Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Keio University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Keio University</source>
  <brief_summary>
    <textblock>
      Combination therapy of glinides with premixed insulin provides better glycemic control than
      premixed insulin alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Type 2 diabetic patients undergoing twice daily injections of premixed insulin are
      administered glinides (10mg of mitiglinide or 90 mg of nateglinide) at lunchtime without
      changing their insulin regimen. Twelve weeks after administration of the glinides, they are
      discontinued. HbA1c levels at the start of glinide administration, 12 weeks after
      administration, and 12 weeks after discontinuation are measured.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2004</start_date>
  <completion_date>March 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>glycohemoglobin</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>anhydroglucitol</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>lipid profile</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body weight</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood pressure</measure>
  </secondary_outcome>
  <enrollment>60</enrollment>
  <condition>Type 2 Diabets Mellitus</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>nateglinide(drug) mitiglinide(drug)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of type 2 diabetes

          -  Who undergoes twice daily injection of premixed insulin

          -  Whose HbA1c is more than 6.5% and less than 8.0%

        Exclusion Criteria:

          -  Whose change of HbA1c is more than 1.0% during 12 weeks observational period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Akira Shimada, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Keio University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yoshihito Atsumi, MD</last_name>
    <role>Study Director</role>
    <affiliation>Saiseikai Central Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nippon Kokan Hospital</name>
      <address>
        <city>Kawasaki</city>
        <state>Kanagawa</state>
        <zip>210-0852</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hamamatsu Red Cross Hospital</name>
      <address>
        <city>Hamamatsu</city>
        <state>Shizuoka</state>
        <zip>430-0907</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saiseikai Central Hospital</name>
      <address>
        <city>Minato-ku</city>
        <state>Tokyo</state>
        <zip>108-0073</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kitasato Institute Hospital</name>
      <address>
        <city>Minato-ku</city>
        <state>Tokyo</state>
        <zip>108-8642</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Keio University Hospital</name>
      <address>
        <city>Shinjuku-ku</city>
        <state>Tokyo</state>
        <zip>160-8582</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tokyo Metropolitan Ohtsuka Hospital</name>
      <address>
        <city>Toshima-ku</city>
        <state>Tokyo</state>
        <zip>170-8476</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 28, 2006</study_first_submitted>
  <study_first_submitted_qc>August 28, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 29, 2006</study_first_posted>
  <last_update_submitted>August 25, 2009</last_update_submitted>
  <last_update_submitted_qc>August 25, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 26, 2009</last_update_posted>
  <keyword>glinides</keyword>
  <keyword>premixed insulin</keyword>
  <keyword>combination therapy</keyword>
  <keyword>glycemic control</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Nateglinide</mesh_term>
    <mesh_term>Mitiglinide</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

